Wilson, M. P., Garanto, A., Pinto e Vairo, F., Ng, B. G., Ranatunga, W. K., Ventouratou, M., . . . Lefeber, D. J. (2021). Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings. The American journal of human genetics, 108(11), . https://doi.org/10.1016/j.ajhg.2021.09.012
Chicago-Zitierstil (17. Ausg.)Wilson, Matthew P., et al. "Active Site Variants in STT3A Cause a Dominant Type I Congenital Disorder of Glycosylation with Neuromusculoskeletal Findings." The American Journal of Human Genetics 108, no. 11 (2021). https://doi.org/10.1016/j.ajhg.2021.09.012.
MLA-Zitierstil (9. Ausg.)Wilson, Matthew P., et al. "Active Site Variants in STT3A Cause a Dominant Type I Congenital Disorder of Glycosylation with Neuromusculoskeletal Findings." The American Journal of Human Genetics, vol. 108, no. 11, 2021, https://doi.org/10.1016/j.ajhg.2021.09.012.